Edition:
United States

Titan Pharmaceuticals Inc (TTNP.OQ)

TTNP.OQ on NASDAQ Stock Exchange Capital Market

1.23USD
15 Dec 2017
Change (% chg)

$-0.03 (-2.00%)
Prev Close
$1.25
Open
$1.25
Day's High
$1.25
Day's Low
$1.20
Volume
23,789
Avg. Vol
30,910
52-wk High
$4.75
52-wk Low
$1.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.04 -0.198
Jun '17 0.08 -0.163
Mar '17 0.04 -0.142
FY 2016 Dec '16 0.04 -0.110
Sep '16 0.03 -0.124
Jun '16 15.00 0.545
Mar '16 0.00 -0.092
FY 2015 Dec '15 0.00 -0.114
Sep '15 0.00 -0.090
Jun '15 0.76 -0.114
Mar '15 0.91 -0.244
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 1 0.05 0.05 0.05 --
Year Ending Dec-17 1 0.20 0.20 0.20 2.58
Year Ending Dec-18 1 0.61 0.61 0.61 7.49
Earnings (per share)
Quarter Ending Dec-17 1 -0.15 -0.15 -0.15 --
Year Ending Dec-17 1 -0.65 -0.65 -0.65 -0.40
Year Ending Dec-18 1 -0.45 -0.45 -0.45 -0.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.20 35.91
P/E High - Last 5 Yrs. 16.72 40.75 45.35
P/E Low - Last 5 Yrs. 5.15 23.60 24.23
Beta 2.15 0.92 0.91
Price to Sales (TTM) 135.28 3.92 5.95
Price to Book (MRQ) 6.43 4.85 5.68
Price to Tangible Book (MRQ) 6.43 5.73 7.29
Price to Cash Flow (TTM) -- 23.05 24.49
% Owned Institutions 9.03 0.87 1.41

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.49
Dividend Yield - 5 Year Avg -- 2.17 2.05
Dividend 5 Year Growth Rate -- 4.29 5.25
Payout Ratio(TTM) -- 47.47 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 53.85 6.31 6.79
Sales (TTM) vs TTM 1 Yr. Ago -98.72 5.15 5.62
Sales - 5 Yr. Growth Rate 29.93 9.99 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago -59.92 7.11 7.85
EPS (TTM) vs TTM 1 Yr. Ago -384.27 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.94
Capital Spending - 5 Yr. Growth Rate -6.24 15.15 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.49 2.55
Current Ratio (MRQ) 6.11 3.50 3.56
LT Debt to Equity (MRQ) 166.54 11.01 13.38
Total Debt to Equity (MRQ) 166.54 17.15 19.38
Interest Coverage (TTM) -- 49.64 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.26 54.91
Gross Margin - 5 Yr. Avg. -- 52.35 52.46
EBITD Margin (TTM) -7,279.17 -- --
EBITD - 5 Yr. Avg -36.70 18.50 15.63
Operating Margin (TTM) -7,490.62 14.76 6.56
Operating Margin - 5 Yr. Avg. -39.89 14.33 11.00
Pre-Tax Margin (TTM) -6,757.29 15.21 7.41
Pre-Tax Margin - 5 Yr. Avg. -36.90 14.64 11.41
Net Profit Margin (TTM) -6,757.29 11.39 3.64
Net Profit Margin - 5 Yr. Avg. -36.90 10.98 7.70
Effective Tax Rate (TTM) -- 24.38 24.28
Effective Tax Rate - 5 Yr. Avg. -- 23.46 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 13,714 945,342,213 851,801,741
Net Income/Employee (TTM) -926,714 110,573,246 99,542,701
Receivable Turnover (TTM) 0.06 5.90 6.13
Inventory Turnover (TTM) -- 2.73 3.56
Asset Turnover (TTM) 0.01 0.99 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -71.53 11.86 11.31
Return on Assets - 5 Yr. Avg. -15.26 12.86 12.28
Return on Investment (TTM) -94.07 15.06 14.43
Return on Investment - 5 Yr. Avg. -32.53 16.81 16.07
Return on Equity (TTM) -134.45 16.55 16.01
Return on Equity - 5 Yr. Avg. -- 17.82 17.27
  1 Year 3 Year 5 Year
Sales % 801.56 12.86 29.93
EPS (TTM) % 142.54 -28.19 --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Titan Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 9.03%
# of Holders: 45
Total Shares Held: 1,914,330
3 Mo. Net Change: -907,279
# New Positions: 3
# Closed Positions: 21
# Increased Positions: 8
# Reduced Positions: 34
# Net Buyers: -26
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.